Abstract

Tamm-Horsfall glycoprotein (THP) has been described as a promoter or inhibitor of the aggregation of calcium oxalate monohydrate (COM) crystals (1). We have asked whether urinary THP from normal subjects (n THP) and idiopathic calcium oxalate stone formers (sf THP) and THP from human calcium oxalate stones (stone THP) differ in their ability to inhibit the aggregation of COM crystals in vitro, and - if such differences exist -what could be the mechanism of reduced crystal-aggregation inhibition.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call